UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A computerized scoring system to improve assessment of heparin‐induced thrombocytopenia risk

Journal of thrombosis and haemostasis, 2019-02, Vol.17 (2), p.383-388

2019

Volltextzugriff (PDF)

Mechanism of the cardiotoxic actions of terfenadine

JAMA : the journal of the American Medical Association, 1993-03, Vol.269 (12), p.1532

1993

Volltextzugriff (PDF)

Acute treatment of recent-onset atrial fibrillation and flutter with a tailored dosing regimen of intravenous amiodarone. A randomized, digoxin-controlled study

European heart journal, 1995-04, Vol.16 (4), p.521-528

1995

Volltextzugriff (PDF)

Polymorphism of propafenone metabolism and disposition in man: clinical and pharmacokinetic consequences

Circulation (New York, N.Y.), 1987-04, Vol.75 (4), p.785-791

1987

Volltextzugriff (PDF)

N-Acetylation phenotype and genotype and risk of bladder cancer in benzidine-exposed workers

Carcinogenesis (New York), 1993-04, Vol.14 (4), p.675-678

1993

Volltextzugriff (PDF)

Mechanism of cardiotoxicity of halofantrine

Clinical pharmacology and therapeutics, 2000-05, Vol.67 (5), p.521-529

2000

Volltextzugriff (PDF)

Incidence and clinical features of the quinidine-associated long QT syndrome: Implications for patient care

The American heart journal, 1986-06, Vol.111 (6), p.1088-1093

1986

Volltextzugriff (PDF)

QT prolongation and torsades de pointes among methadone users: reports to the FDA spontaneous reporting system

Pharmacoepidemiology and drug safety, 2005-11, Vol.14 (11), p.747-753

2005

Volltextzugriff (PDF)

Genetically‐determined interaction between propafenone and low dose quinidine: role of active metabolites in modulating net drug effect

British journal of clinical pharmacology, 1989-04, Vol.27 (4), p.435-444

1989

Volltextzugriff (PDF)

Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients

The American journal of medicine, 2003-02, Vol.114 (2), p.135-141

2003

Volltextzugriff (PDF)

Adenosine A1‐receptor occupancy predicts A1‐receptor antagonist effects of N‐0861

Clinical pharmacology and therapeutics, 1998-11, Vol.64 (5), p.536-541

1998

Volltextzugriff (PDF)

Geographic Variation in the Prescription of Schedule II Opioid Analgesics among Outpatients in the United States

Health services research, 2006-06, Vol.41 (3p1), p.837-855

2006

Volltextzugriff (PDF)

Antiarrhythmic activity, electrocardiographic effects and pharmacokinetics of the encainide metabolites O-desmethyl encainide and 3-methoxy-O-desmethyl encainide in man

Circulation (New York, N.Y.), 1988-02, Vol.77 (2), p.380-391

1988

Volltextzugriff (PDF)

Co-inheritance of the polymorphic metabolism of encainide and debrisoquin

Clinical pharmacology and therapeutics, 1986-03, Vol.39 (3), p.282-287

1986

Volltextzugriff (PDF)

Clinical pharmacokinetics of disopyramide

Clinical pharmacokinetics, 1986-05, Vol.11 (3), p.214-222

1986

Volltextzugriff (PDF)

Suppression of ventricular arrhythmias in man by d-propranolol independent of beta-adrenergic receptor blockade

The Journal of clinical investigation, 1990-03, Vol.85 (3), p.836-842

1990

Volltextzugriff (PDF)

Encainide and its metabolites: comparative effects in man on ventricular arrhythmia and electrocardiographic intervals

The Journal of clinical investigation, 1984-02, Vol.73 (2), p.539-547

1984

Volltextzugriff (PDF)

Immediate- versus controlled-release disopyramide: Importance of saturable binding

Clinical pharmacology and therapeutics, 1993-07, Vol.54 (1), p.16-22

1993

Volltextzugriff (PDF)

Antiarrhythmic efficacy, clinical electrophysiology, and pharmacokinetics of 3-methoxy-O-desmethyl encainide (MODE) in patients with inducible ventricular tachycardia or fibrillation

Circulation (New York, N.Y.), 1989-11, Vol.80 (5), p.1247-1258

1989

Volltextzugriff (PDF)

Electrophysiologic effects of intravenous and oral sotalol for sustained ventricular tachycardia secondary to coronary artery disease

The American journal of cardiology, 1988-05, Vol.61 (13), p.1006-1011

1988

Volltextzugriff (PDF)

Suppression of chronic ventricular arrhythmias with propranolol

Circulation (New York, N.Y.), 1979-10, Vol.60 (4), p.819-827

1979

Volltextzugriff (PDF)

Pharmacokinetic and Pharmacodynamic Interaction of N-Acetyl Procainamide and Procainamide in Humans

Journal of cardiovascular pharmacology, 1989-09, Vol.14 (3), p.364-373

1989

Volltextzugriff (PDF)

Mexiletine and tocainide: A comparison of antiarrhythmic efficacy, adverse effects, and predictive value of lidocaine testing

Clinical pharmacology and therapeutics, 1989-05, Vol.45 (5), p.553-561

1989

Volltextzugriff (PDF)

Prospective pharmacokinetically based development of effective infusion regimens for ACC-9358, a new antiarrhythmic drug

Clinical pharmacology and therapeutics, 1991-03, Vol.49 (3), p.314-321

1991

Volltextzugriff (PDF)

Efficacy and safety of ACC-9358, a new antiarrhythmic agent

The American journal of cardiology, 1990-04, Vol.65 (13), p.932-934

1990

Volltextzugriff (PDF)

1 – 25 von 94

Suche als RSS-Feed

Aktive Filter

ThemaAged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(85)
Mit Volltextzugriff
(65)

Publikationsform

Artikel
(94)

Sprache

Englisch
(94)

Erscheinungsjahr

n.n

Thema

Humans
(94)
Male
(83)
Middle Aged
(83)
Life Sciences & Biomedicine
(82)
Science & Technology
(82)
Female
(78)
Adult
(65)
Biological And Medical Sciences
(51)
Medical Sciences
(51)
Pharmacology. Drug Treatments
(25)
Radiology, Nuclear Medicine & Medical Imaging
(25)
Arrhythmias, Cardiac - Drug Therapy
(20)
Adolescent
(19)
Aged, 80 And Over
(19)
Electrocardiography
(19)
Pharmacology & Pharmacy
(18)
Retrospective Studies
(18)
Cardiovascular System
(17)
Contrast Media
(17)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A computerized scoring system to improve assessment of heparin‐induced thrombocytopenia risk

Mechanism of the cardiotoxic actions of terfenadine

Acute treatment of recent-onset atrial fibrillation and flutter with a tailored dosing regimen of intravenous amiodarone. A randomized, digoxin-controlled study

Polymorphism of propafenone metabolism and disposition in man: clinical and pharmacokinetic consequences

N-Acetylation phenotype and genotype and risk of bladder cancer in benzidine-exposed workers

Mechanism of cardiotoxicity of halofantrine

Incidence and clinical features of the quinidine-associated long QT syndrome: Implications for patient care

QT prolongation and torsades de pointes among methadone users: reports to the FDA spontaneous reporting system

Genetically‐determined interaction between propafenone and low dose quinidine: role of active metabolites in modulating net drug effect

Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients

Adenosine A1‐receptor occupancy predicts A1‐receptor antagonist effects of N‐0861

Geographic Variation in the Prescription of Schedule II Opioid Analgesics among Outpatients in the United States

Antiarrhythmic activity, electrocardiographic effects and pharmacokinetics of the encainide metabolites O-desmethyl encainide and 3-methoxy-O-desmethyl encainide in man

Co-inheritance of the polymorphic metabolism of encainide and debrisoquin

Clinical pharmacokinetics of disopyramide

Suppression of ventricular arrhythmias in man by d-propranolol independent of beta-adrenergic receptor blockade

Encainide and its metabolites: comparative effects in man on ventricular arrhythmia and electrocardiographic intervals

Immediate- versus controlled-release disopyramide: Importance of saturable binding

Antiarrhythmic efficacy, clinical electrophysiology, and pharmacokinetics of 3-methoxy-O-desmethyl encainide (MODE) in patients with inducible ventricular tachycardia or fibrillation

Electrophysiologic effects of intravenous and oral sotalol for sustained ventricular tachycardia secondary to coronary artery disease

Suppression of chronic ventricular arrhythmias with propranolol

Pharmacokinetic and Pharmacodynamic Interaction of N-Acetyl Procainamide and Procainamide in Humans

Mexiletine and tocainide: A comparison of antiarrhythmic efficacy, adverse effects, and predictive value of lidocaine testing

Prospective pharmacokinetically based development of effective infusion regimens for ACC-9358, a new antiarrhythmic drug

Efficacy and safety of ACC-9358, a new antiarrhythmic agent

Aktive Filter

Suchergebnisse filtern